Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cBMA in Revision ACL Reconstruction
NCT06311513Phase 4Recruiting
- Sponsor
- Hospital for Special Surgery
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of autologous bone marrow cell concentrate in Post-traumatic osteoarthritis (PTOA), sponsored by Hospital for Special Surgery. Started Jan 2024; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT06311513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06311513.